Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer

Molecular and Cellular Biochemistry

Volumn 355, Issue 1-2, 2011, Pages 173-178

  Dragutinović, Vesna V ^a   Radonjić, Nevena V ^a   Petronijević, Nataša D ^a   Tatić, Svetislav B ^a   Dimitrijević, Ivan B ^b   Radovanović, Nebojša S ^a,b   Krivokapić, Zoran V ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

CA 19 9; CEA; Colorectal cancer; Immunohistochemistry; Matrix metalloproteinases

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GELATINASE A; GELATINASE B;

ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREOPERATIVE PERIOD; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; ZYMOGRAPHY;

ADENOCARCINOMA; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM STAGING; PREOPERATIVE PERIOD; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80051549813     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0851-0     Document Type: Article

References (36)

1. T Wiggers JW Arends B Schutte L Volovics FT Bosman 1988 A multivariate analysis of pathologic prognostic indicators in large bowel cancer Cancer 61 2 386 395 3422035 10.1002/1097-0142(19880115)61:2<386::AID-CNCR2820610231>3. 0.CO;2-J 1:STN:280:DyaL1c%2FnvF2juw%3D%3D (Pubitemid 18056500)
2. M Hollstein D Sidransky B Vogelstein CC Harris 1991 p53 Mutations in human cancers Science 253 5015 49 53 1905840 10.1126/science.1905840 1:CAS:528:DyaK3MXks1Gmurg%3D (Pubitemid 21917115)
3. Liotta LA, Stetler-Stevenson WG (1993) Principles of molecular cell: biology of cancer: cancer metastasis. In: De Vita T, Hellman S, Rosenberg S (eds) Cancer, principles and practice of oncology. J.B. Lippincot Co., Philadelphia, pp 134-149
4. H Nagase JF Woessner Jr 1999 Matrix metalloproteinases J Biol Chem 274 21491 21494 10419448 10.1074/jbc.274.31.21491 1:CAS:528:DyaK1MXltVynu7s%3D (Pubitemid 29359963)
5. S Zucker RM Lysik MH Zarrabi U Moll 1993 M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer Cancer Res 53 140 146 8416738 1:STN:280:DyaK3s7gsFCjsw%3D%3D (Pubitemid 23019389)
6. S Hoikkala P Paakko Y Soini R Makitaro V Kinnula T Turpeenniemi-Hujanen 2005 Tissue MMP-2/TIMP-2-complex are better prognostic factors than serum MMP-2, MMP-9 or TIMP-1 in stage I-III lung carcinoma Cancer Lett 236 125 132 15982804 10.1016/j.canlet.2005.05.012
7. H Ruokolainen P Paakko T Turpeenniemi-Hujanen 2005 Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker Int J Cancer 116 422 427 15818624 10.1002/ijc.21092 1:CAS:528: DC%2BD2MXmtl2kur0%3D (Pubitemid 40993339)
8. KH Shen CW Chi SS Lo HL Kao WY Lui CW Wu 2000 Serum matrix metalloproteinase-9 level associated with stromal reaction in patients with gastric cancer Anticancer Res 20 1307 1310 10810440 1:CAS:528: DC%2BD3cXjtl2rtro%3D
9. A Hayasaka N Suzuki N Fujimoto I Syousuke F Etsuo K Yoshiro S Hiromitsu 1996 Elevated plasma levels of matrix metalloproteinase-9 (92 kDa type IV collagenase/gelatinase B) in hepatocellular carcinoma Hepatology 24 1058 1062 8903375 10.1002/hep.510240513 1:STN:280:DyaK2s%2FmtVensg%3D%3D (Pubitemid 26365903)
10. K Endo Y Maehara H Baba M Yamamoto S Tomisaki A Watanabe Y Kakeji K Sugimachi 1997 Elevated levels of serum and plasma metalloproteinases in patient with gastric cancer Anticancer Res 17 2253 2255 9216697 1:CAS:528: DyaK2sXkvFylsbY%3D
11. A Torii Y Kodera K Uesaka T Kiarai K Yasni T Morimoto Y Yamamura T Kato T Hayakawa N Fujimoto T Kito 1997 Plasma concentration of matrix metalloproteinase 9 in gastric cancer Br J Surg 84 133 136 9043478 10.1002/bjs.1800840147 1:STN:280:DyaK2s7ps1aqtQ%3D%3D (Pubitemid 27033129)
12. CD Souza-Tarla JA Uzuelli AA Machado RF Gerlach JE Tanus-Santos 2005 Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activites Clin Biochem 38 5 410 414 15820769 10.1016/j.clinbiochem.2005.02.010 1:CAS:528:DC%2BD2MXjtV2jtbs%3D
13. RF Gerlach JA Uzuelli CD Souza-Tarla JE Tanus-Santos 2005 Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activites Anal Biochem 344 1 147 149 15950912 10.1016/j.ab.2005.04.038 1:CAS:528:DC%2BD2MXos1amt7k%3D (Pubitemid 41569391)
14. RF Gerlach C Demacq K Jung JE Tanus-Santos 2007 Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-levels in serum versus plasma Clin Biochem 40 1-2 119 123 17150202 10.1016/j.clinbiochem. 2006.10.007 1:CAS:528:DC%2BD2sXhsFKjsg%3D%3D (Pubitemid 46014168)
15. F Manello JE Tanus-Santos CA Meschiari GA Tonti 2008 Differences in the both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices Anal Biochem 374 56 63 10.1016/j.ab.2007.11.020
16. V Dragutinović L Izrael Živković N Radovanović 2009 Relation of matrix metalloproteinase-9 to different stages of tumors in serum of gastric cancer Dig Dis Sci 54 1203 1207 18719998 10.1007/s10620-008-0472-y
17. F Mannello 2008 Serum or plasma samples? the "Cinderella" role of blood collection procedures: preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation Arterioscler Thromb Vasc Biol 28 4 611 614 18354094 10.1161/ATVBAHA.107.159608 1:CAS:528:DC%2BD1cXmsVyitbg%3D (Pubitemid 351651318)
18. RF Gerlach CA Meschiari AM Marcaccini AC Palei VC Sandrim RC Cavalli JE Tanus-Santos 2009 Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions Clin Chem Lab Med 47 7 888 891 19575552 10.1515/CCLM.2009.203 1:CAS:528:DC%2BD1MXpsFOktrc%3D
19. MJ Goldstein EP Mitchell 2005 Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer Cancer Invest 23 4 338 351 16100946 (Pubitemid 41656973)
20. UK Laemmli 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685 5432063 10.1038/227680a0 1:CAS:528:DC%2BD3MXlsFags7s%3D
21. DE Kleiner WG Stetler-Stevenson 1994 Quantative zymography detection of picogram quantities of gelatinases Anal Biochem 218 325 329 8074288 10.1006/abio.1994.1186 1:CAS:528:DyaK2cXkslKktbk%3D (Pubitemid 24141631)
22. MF Leeman JA McKay GI Murray 2002 Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer J Clin Pathol 55 10 758 762 12354802 10.1136/jcp.55.10.758 1:STN:280:DC%2BD38vptlCjtQ%3D%3D (Pubitemid 35231907)
23. S Curran SR Dundas J Buxton MF Leeman R Ramsay GI Murray 2004 Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers Clin Cancer Res 10 24 8229 8234 15623598 10.1158/1078-0432.CCR-04-0424 1:CAS:528:DC%2BD2cXhtFGjsrnK (Pubitemid 40053382)
24. CY Wu MS Wu EP Chiang YJ Chen CJ Chen NH Chi YT Shih GH Chen JT Lin 2007 Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution Clin Cancer Res 13 7 2054 2060 17404086 10.1158/1078-0432.CCR-06-2299 1:CAS:528: DC%2BD2sXjs12rtrk%3D (Pubitemid 46649872)
25. LA Liotta WG Stetler-Stevenson 1990 Metalloproteinases and cancer invasion Semin Cancer Biol 1 99 106 2103492 1:STN:280:DyaK3MzlsF2lsw%3D%3D
26. AF Chambers LM Matrisian 1997 Changing views of the role of matrix metalloproteinases in metastasis J Natl Cancer Inst 89 1260 1270 9293916 10.1093/jnci/89.17.1260 1:CAS:528:DyaK2sXmt1Squ7g%3D (Pubitemid 27371946)
27. WG Stetler-Stevenson 1990 Type IV colagenases in tumor invasion and metastasis Cancer Metastsis Rev 9 289 303 10.1007/BF00049520 1:STN:280:DyaK3M3ms1elsg%3D%3D
28. U Jadhav S Chigurupati SS Lakka S Mohanam 2004 Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells Int J Oncol 25 1407 1414 15492832 1:CAS:528:DC%2BD2cXhtVSktbnJ
29. AR Folgueras AM Pendas LM Sanchez C Lopez-Otin 2004 Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies Int J Dev Biol 48 411 424 15349816 10.1387/ijdb.041811af 1:CAS:528:DC%2BD2cXhtVentLfM (Pubitemid 39360392)
30. S Curran GI Murray 1999 Matrix metalloproteinases in tumour invasion and metastasis J Pathol 189 300 308 10547590 10.1002/(SICI)1096-9896(199911)189: 3<300::AID-PATH456>3.0.CO;2-C 1:CAS:528:DyaK1MXntlGgtbo%3D (Pubitemid 29489213)
31. S Curran SR Dundas J Buxton MF Leeman R Ramsay GI Murray 2004 Matrix metalloproteinase (MMP/TIMP) phenotype identifies poor prognosis colorectal cancer Clin Cancer Res 10 8229 8234 15623598 10.1158/1078-0432.CCR-04-0424 1:CAS:528:DC%2BD2cXhtFGjsrnK (Pubitemid 40053382)
32. GI Murray ME Duncan P O'Neil WT Melvin JE Fothergill 1996 Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer Nat Med 2 461 462 8597958 10.1038/nm0496–461 1:CAS:528:DyaK28XitVKmtrY%3D (Pubitemid 26191919)
33. YB Cho WY Lee SY Song HJ Shin SH Yun HK Chun 2007 Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer Hum Pathol 38 1603 1610 17669467 10.1016/j.humpath.2007.03.018 1:CAS:528:DC%2BD2sXhtF2lsb3O (Pubitemid 47589089)
34. M Langenskiold L Holmdahl P Falk ML Ivarsson 2005 Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer Int J Colorectal Dis 20 245 252 15592677 10.1007/s00384-004-0667-4 (Pubitemid 40553003)
35. M Jeziorska NY Haboubi PF Schofield Y Ogata H Nagase DE Woolley 1994 Distribution of gelatinase B (MMP-9) and type IV collagen in colorectal carcinoma Int J Colorectal Dis 9 141 148 7814988 10.1007/BF00290191 1:STN:280:DyaK2M7hsVGiug%3D%3D (Pubitemid 24247561)
36. L Herszényi F Sipos O Galamb N Solymosi I Hritz P Miheller L Berczi B Molnár Z Tulassay 2008 Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon Pathol Oncol Res 14 1 31 37 18347934 10.1007/s12253-008-9004-5